Clinical Outcomes of Patients With COVID19

Guangzhou Institute of Respiratory Disease

Overview

As of February 17th, 2020, China has 70635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths. Human-to-human spread of virus via respiratory droplets is currently considered to be the main route of transmission. The number of patients increased rapidly but the impact factors of clinical outcomes among hospitalized patients are still unclear.

Study Type

OBSERVATIONAL

Conditions

Coronavirus Disease 2019

Interventions

retrospective analysisOTHER

The investigators retrospectively analyzed the hospitalized patients with COVID-19.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Hospitalized patients with COVID19 Exclusion Criteria: * Suspected patients with COVID19, not confirmed by the laboratory * Patients who are refused to receive medical treatments

Locations (1)

HuiZhou Municipal Central Hospital

Huizhou, Guangdong, China

Outcomes

Primary Outcomes

Time to negative conversion of severe acute respiratory syndrome coronavirus 2

The primary outcome is the time to negative conversion of coronavirus

Time frame: 1 month

Secondary Outcomes

Length of stay in hospital

The time of hospitalization.

Time frame: 1 month

Survival

The rate of survival within hospitalization of these patients will be tracked.

Time frame: 1 month

Intubation

The rate of intubation within hospitalization of these patients will be tracked.

Time frame: 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.